amsacrine has been researched along with Carcinoma, Bronchial in 2 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creech, RH | 2 |
Tritchler, D | 1 |
Ettinger, DS | 2 |
Ferraro, JA | 2 |
Ruckdeschel, JC | 2 |
Vogl, SE | 2 |
Woll, J | 1 |
Day, R | 1 |
Woll, JE | 1 |
2 trials available for amsacrine and Carcinoma, Bronchial
Article | Year |
---|---|
Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).
Topics: Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspartic Acid; Carcin | 1984 |
A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma. An Eastern Cooperative Group Study.
Topics: Aged; Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Bron | 1983 |